Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma.

Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2015

Koole Koos, van Kempen Pauline M W, van Bockel Liselotte W, Smets Timo, van der Klooster Zoë, Dutman Annemiek C, Peeters Ton, Koole Ron, van Diest Paul, van Es Robert J J, Willems Stefan M

Abstract excerpt

OBJECTIVE: The aim of this study was to investigate whether fibroblast growth factor receptor 4 (FGFR4) could serve as a potential therapeutic target, prognostic biomarker or biomarker predicting radiotherapy sensitivity in oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC). METHODS: FGFR4 immunohistochemistry and FGFR4/CEN5q FISH were performed on tissue microarrays from 212...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Mouth Neoplasms

Share to Oropharyngeal Neoplasms

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Tissue Array Analysis

Share to Up-Regulation

Source

Identifiers

PMID: 26551585
DOI: 10.1159/000439536

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma.PMID 26551585Read ↗

Roles of FGFR in oral carcinogenesis.Semantic proximity Read ↗

Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.Semantic proximity Read ↗

FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.Semantic proximity Read ↗

FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.Semantic proximity Read ↗

The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung CancerSemantic proximity Read ↗

Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low‐risk patient as defined by targeted sequencingSemantic proximity Read ↗

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.Semantic proximity Read ↗

ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.